Speaker Profile

Ph.D., Associate Professor, UBC

Biography
Mark Harrison is an Associate Professor with the University of British Columbia’s Faculty of Pharmaceutical Sciences and leads a health economics program within the Collaboration for Outcomes Research and Evaluation (CORE) group. His program of research considers patient-physician decision-making, understanding the role of preferences in treatment decisions, and evaluating the impact of policy interventions on patient and health care system outcomes. Increasingly Mark is looking to study the access to health care of marginalized populations and the relationship between health/health care and the environment.


 Session Abstract – PMWC 2023 Silicon Valley


Track 1, January 25

Track Co-Chairs:
Yael Weiss, Mahzi
Peter Marks, FDA

  • Welcome and Opening by Track Chairs: Yael Weiss, Mahzi & Peter Marks, FDA
  • Patient Driven Therapies: The Challenges and Successes (PANEL)
    Chair: Yael Weiss, Mahzi
    - Allyson Berent, Angelman Foundation
    - Terry Pirovolakis, CureSPG50
  • From Bench to Bedside - Biomarkers, Natural History Studies, Animal Models (PANEL)
    Chair: Peter Marks, FDA
    - Emil Kakkis, Ultragenyx
    - Alysson Muotri, UCSD
    - Nasha Fitter, Invitae
  • Commercialization - Moving from Rare to Common (PANEL)
    Chair: John Maraganore, Alnylam Pharmaceuticals
    - Shankar Ramaswamy, Kriya
    - Rahul Singhvi, Resilience
    - Andrew Lo, MIT
    - Mark Harrison, University of British Colombia
  • Future Modalities (PANEL)
    Chair: Shannon Muir, CIAPM
    - Nadav Ahituv, UCSF
  • Bioethics & Ethical Implications in Cell and Gene Therapies
    - Hank Greely, Stanford